GLP1R and endometrial cancer: Hence, Zhang and her team conducted research to assess how the anti-diabetes drug exendin-4, a GLP-1 receptor agonist, affects human endometrial cancer cells' reaction to chemotherapy following extended exposure to elevated glucose levels.